| 21-Nov-25 |
Buy |
David Ranken Gammon |
305.52p | 12,000 |
£36,662.40 |
| 21-Nov-25 |
Buy |
David Ranken Gammon |
305.52p | 12,000 |
£36,662.40 |
| 17-Nov-25 |
Buy |
Eben Upton CBE |
329.51p | 6,036 |
£19,889.22 |
| 05-Nov-25 |
Buy |
Eben Upton CBE |
342.87p | 5,832 |
£19,996.18 |
| 21-Nov-25 |
Buy |
David Ranken Gammon |
305.52p | 12,000 |
£36,662.40 |
| 21-Nov-25 |
Buy |
David Ranken Gammon |
305.52p | 12,000 |
£36,662.40 |
| 05-Nov-25 |
Buy |
Eben Upton CBE |
342.87p | 5,832 |
£19,996.18 |
| 17-Nov-25 |
Buy |
Eben Upton CBE |
329.51p | 6,036 |
£19,889.22 |
| Eben Upton CBE |
2,513,004 |
£8,182,341 |
| Richard David Boult |
475,602 |
£1,548,560 |
| Martin Hellawell |
75,751 |
£246,645 |
| Daniel Labbad |
34,727 |
£113,071 |
| Rachel Izzard |
21,851 |
£71,147 |
| David Ranken Gammon |
12,000 |
£39,072 |
| Raspberry Pi Foundation |
90,326,121 |
£294,101,850 |
| Arm Technology Investments 2 Limited |
16,252,185 |
£52,917,114 |
| Lansdowne Developed Markets Master Fund Limited |
12,211,426 |
£39,760,403 |
| SW INVESTMENT MANAGEMENT LLC |
7,902,519 |
£25,730,602 |
| Employee Benefit Trust |
6,592,359 |
£21,464,721 |
| Ezrah Charitable Trust |
6,430,098 |
£20,936,399 |
| Hargreaves Lansdown |
5,978,981 |
£19,467,562 |
| 17:08 |
2,500 @ 325.60p |
| 15:34 |
60 @ 324.80p |
| 16:35 |
66,651 @ 325.60p |
| 16:35 |
15 @ 325.60p |
| 16:35 |
116 @ 325.60p |
Top of Page
You are here:
research